Stock listing

Thx Pharma

Selected listing: A2H6LX · LS · EUR · DE

Thx Pharma (Lang & Schwarz: A2H6LX), Health Technology. Latest release Sep 29, 2026: Thx Pharma : THX PHARMA REPORTS ITS FINANCIAL RESULTS FOR THE FIRST HALF…

A2H6LX:LSEURDEUpdated October 3, 2026

Ticker: Lang & Schwarz: A2H6LX
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

About Thx Pharma

The company focuses on pharmaceutical development and innovation. Thx Pharma is committed to advancing healthcare solutions through its research and product offerings.

Latest news from Thx Pharma

Thx Pharma : THX PHARMA REPORTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2026

September 29, 2026

THX PHARMA REPORTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2026

September 28, 2026

THX PHARMA ANNONCE SES RESULTATS FINANCIERS DU PREMIER SEMESTRE 2026

September 28, 2026

Rapport semestriel THX Pharma

September 28, 2026

Thx Pharma : Corrected press release : THX Pharma and the Beyond Batten Disease Foundation Announce the Grant of a European Patent Protecting the Use of Batten-1 in Juvenile Batten Disease (CLN3)

September 9, 2026

All Thx Pharma news →

Research Thx Pharma

Thx Pharma company profile

View the public company page for Thx Pharma on 6ix.

Thx Pharma news

Read company news and market updates connected to Thx Pharma.

Thx Pharma investor events

Find investor webinars, events, and replay context for Thx Pharma.